BERNHARD-NOCHT-INSTITUT FUER TROPENMEDIZIN
- Country
- Germany
- Type
- Beneficiary
- Website
- www.bni.uni-hamburg.de
- Grants received
- 32
Funding record
- 32 grants on record
- €16,358,087.59 awarded in total
- 2008–2025 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
13 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- INSTITUT PASTEUR
- ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI-ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
- Department of Health
- ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
- INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT
- UNIVERSITE D'AIX MARSEILLE
Calls from this organisation
No published calls from this organisation.
Grants received
- Identification of novel viral entry factors and development of antiviral approaches
- Clinical evaluation of AntimalarialS tri-therapy with AtovAquone-Proguanil for treatment of uncomplicated malaria in African children
- European Viral Outbreak Response Alliance
- Development of novel viral vectored vaccines against Marburgviruses inducing robust and cross-reactive protection
- The Integrate study : An adaptive platform trial for the development of a new intervention to combat Lassa fever in Africa
- Enabling the WHO-Roadmap 2030
- MOBILISE: A novel and green mobile One Health laboratory for (re-)emerging infectious disease outbreaks
- Integrated Services for Infectious Disease Outbreak Research
- Cellular basis of Artemisinin resistance in malaria parasites
- Equine Polyclonal antibodies Immunotherapy against COVID-19/SARS-CoV2–VOC
- Improved Vaccination Strategies for Older Adults
- EuroGEO Showcases: Applications Powered by Europe
- Advancing European Research Infrastcuture on Highly Pathogenic Agents
- PAN EBOLA VACCINE INNOVATIVE APPROACH – Sofia ref.: 116088
- Evaluation of species-specific ebolavirus pathophysiology in xenochimeric mice
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.